Interaction of Discoidin Domain Receptor 1 with a 14-3-3-Beclin-1-Akt1 Complex Modulates Glioblastoma Therapy Sensitivity.

Glioblastoma (GBM) is highly refractory to therapy and associated with poor clinical outcome. Here, we reveal a critical function of the promitotic and adhesion-mediating discoidin domain receptor 1 (DDR1) in modulating GBM therapy resistance. In GBM cultures and clinical samples, we show a DDR1 and GBM stem cell marker co-expression that correlates with patient outcome. We demonstrate that inhibition of DDR1 in combination with radiochemotherapy with temozolomide in GBM models enhances sensitivity and prolongs survival superior to conventional therapy. We identify a 14-3-3-Beclin-1-Akt1 protein complex assembling with DDR1 to be required for prosurvival Akt and mTOR signaling and regulation of autophagy-associated therapy sensitivity. Our results uncover a mechanism driven by DDR1 that controls GBM therapy resistance and provide a rationale target for the development of therapy-sensitizing agents.

• Publication year

  2019

• Venue

  Cell Reports

• Publication date

  2019-03-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.celrep.2019.02.096PMID 30917320
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CONTACT FOR REAGENT AND RESOURCE SHARING

  2018cited by this paper
• Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

  2018cited by this paper
• Adhesion- and stress-related adaptation of glioma radiochemoresistance is circumvented by β1 integrin/JNK co-targeting

  2017cited by this paper
• A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma.

  2017cited by this paper
• Involvement of proapoptotic genes in autophagic cell death induced by irradiation

  2017cited by this paper
• Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy

  2017cited by this paper
• Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression

  2017cited by this paper
• Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma.

  2017cited by this paper
• Amyloid-β(1–42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity *

  2016cited by this paper
• Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance

  2016cited by this paper
• Association of collagen architecture with glioblastoma patient survival.

  2016cited by this paper
• The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

  2016cited by this paper
• Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma

  2016cited by this paper
• Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer.

  2016cited by this paper
• Brain tumour cells interconnect to a functional and resistant network

  2015cited by this paper
• Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance.

  2015cited by this paper
• Focal adhesion signaling and therapy resistance in cancer.

  2015cited by this paper
• Autophagy-based survival prognosis in human colorectal carcinoma

  2015cited by this paper
• Simultaneous β1 integrin-EGFR targeting and radiosensitization of human head and neck cancer.

  2015cited by this paper
• Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy

  2015influential reference
• Glioma

  2015cited by this paper
• Radiosensitization of Primary Human Glioblastoma Stem-like Cells with Low-Dose AKT Inhibition

  2015cited by this paper
• Type 1 collagen as a potential niche component for CD133‐positive glioblastoma cells

  2014cited by this paper
• Normal Activation of Discoidin Domain Receptor 1 Mutants with Disulfide Cross-links, Insertions, or Deletions in the Extracellular Juxtamembrane Region

  2014cited by this paper
• A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme

  2014influential reference
• Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma

  2014influential reference
• Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial.

  2014cited by this paper
• Cancer drug resistance: an evolving paradigm

  2013cited by this paper
• Invasion as target for therapy of glioblastoma multiforme.

  2013cited by this paper
• β₁Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy.

  2012influential reference
• Discoidin Domain Receptors Promote α1β1- and α2β1-Integrin Mediated Cell Adhesion to Collagen by Enhancing Integrin Activation

  2012influential reference
• Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation

  2012influential reference
• 14-3-3 proteins as potential therapeutic targets.

  2011influential reference
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• The role of integrins in glioma biology and anti-glioma therapies.

  2011cited by this paper
• A Role for Fibrillar Collagen Deposition and the Collagen Internalization Receptor Endo180 in Glioma Invasion

  2010cited by this paper
• Integrin signalling adaptors: not only figurants in the cancer story

  2010cited by this paper
• Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

  2010cited by this paper
• PINCH1 regulates Akt1 activation and enhances radioresistance by inhibiting PP1alpha.

  2010influential reference
• The Pan-Bcl-2 Inhibitor (−)-Gossypol Triggers Autophagic Cell Death in Malignant Glioma

  2010cited by this paper
• Integrin alpha 6 regulates glioblastoma stem cells.

  2010cited by this paper
• Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma

  2009cited by this paper
• Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

  2009cited by this paper
• Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1–phosphatidylinositol-3-kinase complex

  2009cited by this paper
• GPS 2.0, a Tool to Predict Kinase-specific Phosphorylation Sites in Hierarchy *S

  2008influential reference
• Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

  2008cited by this paper
• Expression of Integrin-linked Kinase Is Increased in Differentiated Cells

  2008cited by this paper
• Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria

  2008cited by this paper
• Comprehensive genomic characterization defines human glioblastoma genes and core pathways

  2008cited by this paper
• Chromatin Central: towards the comparative proteome by accurate mapping of the yeast proteomic environment

  2008cited by this paper
• Discoidin Domain Receptor-1a (DDR1a) Promotes Glioma Cell Invasion and Adhesion in Association with Matrix Metalloproteinase-2

  2006cited by this paper
• Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy.

  2005cited by this paper
• PixFRET, an ImageJ plug‐in for FRET calculation that can accommodate variations in spectral bleed‐throughs

  2005cited by this paper
• Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells

  2004cited by this paper
• p53 induction and activation of DDR1 kinase counteract p53‐mediated apoptosis and influence p53 regulation through a positive feedback loop

  2003cited by this paper
• Cytoscape: a software environment for integrated models of biomolecular interaction networks.

  2003cited by this paper
• Gene Ontology: tool for the unification of biology

  2000cited by this paper
• Consistent and Selective Expression of the Discoidin Domain Receptor-1 Tyrosine Kinase in Human Brain Tumors

  2000cited by this paper

• The Extracellular Matrix, the Silent ‘Architect’ of Glioma

  2026cites this paper
• A novel role of exostosin glycosyltransferase 2 (EXT2) in glioblastoma cell metabolism, radiosensitivity and ferroptosis

  2025influential citation
• Emerging strategies and translational advancements of DDR1 in oncology

  2025cites this paper
• Discoidin domain receptor inhibitor DDR1-IN-1 induces autophagy and necroptotic cell death in malignant peripheral nerve sheath tumor

  2025cites this paper
• Collagen remodeling-mediated signaling pathways and their impact on tumor therapy

  2025cites this paper
• Inhibition of DDR1 potentiates carbon ion radiotherapy by promoting ferroptosis and immunogenic death in head and neck squamous cell carcinoma

  2025cites this paper
• Collagen in pituitary adenomas: A comprehensive review of biological roles and clinical implications

  2025cites this paper
• Collagen type IV alpha 6 promotes tumor progression and chemoresistance in ovarian cancer by activating the discoidin domain receptor 1 pathway

  2025cites this paper
• Unraveling Botulinum Neurotoxin A Light-Chain-Induced Signaling Pathways: A Phosphoproteomic Analysis in a Controlled Cellular Model

  2025cites this paper
• DDR1 is identified as an immunotherapy target for microsatellite stable colon cancer by CRISPR screening

  2024cites this paper
• Functional Role of DDR1 in Oligodendrocyte Signaling Mechanism in Association with Myelination and Remyelination Process in the Central Nerve System.

  2024cites this paper
• Aqueous extracts from Dioscorea sansibarensis Pax show cytotoxic and radiosensitizing potential in 3D growing HPV-negative and HPV-positive human head and neck squamous cell carcinoma models.

  2024cites this paper
• Inhibition of DDR1 promotes ferroptosis and overcomes gefitinib resistance in non-small cell lung cancer.

  2024cites this paper
• DDR1 Drives Malignant Progression of Gastric Cancer by Suppressing HIF‐1α Ubiquitination and Degradation

  2024cites this paper
• Mechanistic insights and the clinical prospects of targeted therapies for glioblastoma: a comprehensive review

  2024cites this paper
• β1 integrin mediates unresponsiveness to PI3Kα inhibition for radiochemosensitization of 3D HNSCC models

  2024cites this paper
• Discoidin Domain Receptor 1 as a potent therapeutic target in solid tumors

  2024cites this paper
• Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment

  2024cites this paper
• Bivalent activity of super-enhancer RNA LINC02454 controls 3D chromatin structure and regulates glioma sensitivity to temozolomide

  2024cites this paper
• Scaffold-Based (Matrigel™) 3D Culture Technique of Glioblastoma Recovers a Patient-like Immunosuppressive Phenotype

  2023cites this paper
• The ABL-MYC axis controls WIPI1-enhanced autophagy in lifespan extension

  2023cites this paper
• Blockade of DDR1/PYK2/ERK signaling suggesting SH2 superbinder as a novel autophagy inhibitor for pancreatic cancer

  2023cites this paper
• Simultaneous inhibition of discoidin domain receptor 1 and integrin αVβ3 radiosensitizes human glioblastoma cells.

  2023cites this paper
• DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors

  2023cites this paper
• ABL1/2 and DDR1 Drive MEKi Resistance in NRAS-Mutant Melanomas by Stabilizing RAF/MYC/ETS1 and Promoting RAF Homodimerization

  2023cites this paper
• A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance

  2023cites this paper
• Meta-analysis of expression and the targeting of cell adhesion associated genes in nine cancer types – A one research lab re-evaluation

  2023cites this paper
• Human type III collagen-derived biomaterial with high antitumor activity inhibits breast cancer cell autophagy, proliferation, and migration through DDR1.

  2023cites this paper
• TanshinoneⅡA inhibits excessive autophagy and protects myocardium against ischemia/reperfusion injury via 14-3-3η/Akt/Beclin1 pathway.

  2023cites this paper
• Multifaceted collagen-DDR1 signaling in cancer.

  2023cites this paper
• A network map of discoidin domain receptor 1(DDR1)-mediated signaling in pathological conditions

  2022cites this paper
• DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6

  2022cites this paper
• Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma

  2022cites this paper
• Targeting of p21-Activated Kinase 4 Radiosensitizes Glioblastoma Cells via Impaired DNA Repair

  2022cites this paper
• MicroRNA-640 Inhibition Enhances the Chemosensitivity of Human Glioblastoma Cells to Temozolomide by Targeting Bcl2 Modifying Factor

  2022cites this paper
• Unveiling the Mechanism of the Traditional Korean Medicinal Formula FDY003 on Glioblastoma Through a Computational Network Pharmacology Approach

  2022cites this paper
• Targeting integrin α2 as potential strategy for radiochemosensitization of glioblastoma.

  2022cites this paper
• Lamellipodin-RICTOR Signaling Mediates Glioblastoma Cell Invasion and Radiosensitivity Downstream of EGFR

  2021cites this paper
• Understanding signal transduction pathways to overcome targeted therapy resistance in glioblastoma

  2021cites this paper
• Parallels between the extracellular matrix roles in developmental biology and cancer biology.

  2021cites this paper
• Discoidin domain receptors (DDRs): Potential implications in periodontitis

  2021cites this paper
• Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations

  2021cites this paper
• Targeted Proteomic Analysis Revealed Kinome Reprogramming during Acquisition of Radioresistance in Breast Cancer Cells.

  2021cites this paper
• Long non-coding RNA LINC00470 in serum derived exosome: a critical regulator for proliferation and autophagy in glioma cells

  2021cites this paper
• Function and regulation of phosphatase 1 in healthy and diseased heart.

  2021cites this paper
• Inhibitors of Discoidin Domain Receptor (DDR) Kinases for Cancer and Inflammation

  2021cites this paper
• The Intermediate Filament Synemin Regulates Non-Homologous End Joining in an ATM-Dependent Manner

  2020cites this paper
• The beclin 1 interactome: Modification and roles in the pathology of autophagy-related disorders.

  2020cites this paper
• Meeting report – first discoidin domain receptors meeting

  2020cites this paper
• Discoidin Domain Receptor 1 functionally interacts with the IGF-I system in bladder cancer

  2020cites this paper
• Regulation of Beclin 1-Mediated Autophagy by Oncogenic Tyrosine Kinases

  2020cites this paper
• Discovery of 4-amino-1H-pyrazolo[3,4-d]pyrimidin derivatives as novel discoidin domain receptor 1 (DDR1) inhibitors.

  2020cites this paper
• Discoidin Domain Receptor 1 is a therapeutic target for neurodegenerative diseases.

  2020cites this paper
• Keap1 inhibition sensitizes head and neck squamous cell carcinoma cells to ionizing radiation via impaired non-homologous end joining and induced autophagy

  2020cites this paper
• Therapeutic Potential of Autophagy in Glioblastoma Treatment With Phosphoinositide 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin Signaling Pathway Inhibitors

  2020cites this paper
• Curcumin induces apoptosis in lung cancer cells by 14-3-3 protein-mediated activation of Bad

  2020cites this paper
• Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma.

  2020cites this paper
• Targeting the Extra-Cellular Matrix—Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors

  2020cites this paper
• DDR1 promotes breast tumor growth by suppressing antitumor immunity.

  2019cites this paper
• 1,3-Dicaffeoylquinic acid targeting 14-3-3 tau suppresses human breast cancer cell proliferation and metastasis through IL6/JAK2/PI3K pathway.

  2019cites this paper
• Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1

  2019cites this paper
• DDR1 (discoidin domain receptor tyrosine kinase 1) drives glioblastoma therapy resistance by modulating autophagy

  2019cites this paper